ALERRT COVID-19 Clinical Characterisation Protocol

ALERRT has worked closely with the WHO/AFRO, Africa CDC and existing networks and structures across Africa and globally to adapt the ISARIC clinical characterisation protocol (CCP) for COVID-19 for implementation in Africa. The ‘Africa ready’ core documents and guidance for operationalising the ALERRT CCP are available here. 

This work was supported by the UK Foreign, Commonwealth and Development Office and Wellcome [221012/Z/20/Z]

COVID-19 Webinars

ALERRT partnered with the African Academy of Sciences, Africa CDC and WHO AFRO and PANDORA-ID-NET to deliver two webinars on treatments for COVID-19 and the clinical research landscape in Africa.